Literature DB >> 4236499

The antagonism between reserpine and some antiparkinson drugs in electroseizure.

I Jurna, B Regélhy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4236499     DOI: 10.1007/bf00538559

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol


× No keyword cloud information.
  42 in total

1.  EFFECTS OF D-AMPHETAMINE AND RESTRAINT ON THE CONTENT OF NOREPINEPHRINE AND DOPAMINE IN RAT BRAIN.

Authors:  K E MOORE; E W LARIVIERE
Journal:  Biochem Pharmacol       Date:  1963-11       Impact factor: 5.858

2.  THE EFFECTS OF COCAINE, AMPHETAMINE AND SOME AMPHETAMINE-LIKE COMPOUNDS ON THE IN VIVO LEVELS OF NORADRENALINE AND DOPAMINE IN THE RAT BRAIN.

Authors:  J R BAIRD; J J LEWIS
Journal:  Biochem Pharmacol       Date:  1964-11       Impact factor: 5.858

3.  [ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Arch Psychiatr Nervenkr       Date:  1964-12-02

4.  [Modifications by reserpine of the symptomatology of convulsive attacks induced in rabbits. Study of the neuromuscular paralyzants].

Authors:  J REUSE
Journal:  C R Hebd Seances Acad Sci       Date:  1960-11-14

5.  3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON
Journal:  Nature       Date:  1957-11-30       Impact factor: 49.962

6.  The vasopressor action and toxicity of cyclohexylethylamine derivatives.

Authors:  A M LANDS; J I GRANT
Journal:  J Pharmacol Exp Ther       Date:  1952-11       Impact factor: 4.030

7.  Subcellular localization of H3-norepinephrine in the rat brain and the effect of drugs.

Authors:  J Glowinski; S H Snyder; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1966-05       Impact factor: 4.030

8.  Striatal and spinal lesions eliminating reserpine and physostigmine rigidity.

Authors:  J Arvidsson; I Jurna; G Steg
Journal:  Life Sci       Date:  1967-10-01       Impact factor: 5.037

9.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

10.  Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects.

Authors:  G P QUINN; P A SHORE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1959-10       Impact factor: 4.030

View more
  4 in total

1.  The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.

Authors:  I Jurna; C Theres; T Bachmann
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

2.  Depression by antiparkinson drugs of reserpine rigidity.

Authors:  I Jurna
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968-05-07

3.  Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.

Authors:  I Jurna; G Lanzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

4.  Partial protection against hyperbaric oxygen induced convulsions by dopaminergic agents in mice: possible involvement of autoreceptors?

Authors:  C O Criborn; C Henriksson; S Ahlenius; V Hillegaart
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.